Home > Offer to Sell > Other Chemicals > Others > Flibanserin CAS:167933-07-5 cheryl@chembj.com

Flibanserin CAS:167933-07-5 cheryl@chembj.com

Inquiry
  Post Date: Dec 31,2015
  Expiry Date: Dec 30,2016
  Detailed Description: Quantity: 3000Kilograms
Specs:cheryl@chembj.com
Price:1 USD Kilograms
Payment Method: T/T , Moneygram , Westunion,Bitcoin
Female Sex Enhancement Powder Flibanserin CAS:167933-07-5
Women Sexual Desire Disorder Flibanserin CAS:167933-07-5

Flibanserin CAS:167933-07-5
Molecular formula: C20H21F3N4O
Molecular weight: 390.4
purity: 99%
Appearance: White powder
Grade: Pharmaceutical grade
Usage:adrug being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder
Catagory: Pharmaceutical raw material female sex enhance

Introduction:HSDD is the most commonly reported form of female sexual dysfunction. HSDD is defined as a persistent or recurrent deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty, and which is not better accounted for by a medical, substance-related, psychiatric (e.g., depression) or other sexual condition. The cause of HSDD is believed to involve a multitude of social, psychological and biological factors and may be attributed to a complex interplay of these factors.

Applications: A new drug designed to boost sexual desire in women is controversial for some and eagerly awaited by others, but it's hit a potentially serious snag. The drug didn't boost women's desire any more than a placebo in two clinical trials.

The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels. ) Although there was a slight increase in the number of sexually satisfying events flibanserin users had each month, the FDA staff who reviewed the results said the so-called response rate isn't "particularly compelling.

It's called the "little pink pill, " a tiny tablet that could have a huge impact on treating female sexual dysfunction. If it's approved, it would become the first drug of its kind on the market.


  Company: Hubei Yuancheng Saichuang Technology Co., Ltd     [ China ]        
  Contact: Cheryl
  Tel: 8618771024715
  Fax:
  Email: cheryl@chembj.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.